Test method: GH

Bailliere's Best Practice and Research in Clinical Endocrinology and Metabolism

Volumn 14, Issue 1, 2000, Pages 99-109

  Bidlingmaier, Martin ^a   Wu, Zida ^a   Strasburger, Christian J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

ALS; Growth hormone; IGF 1; IGFBP 3; Immunoassay; Isoforms; Recombinant growth hormone

Indexed keywords

RECOMBINANT GROWTH HORMONE;

DOPING; DRUG ABUSE; HUMAN; IMMUNOASSAY; PHYSICAL PERFORMANCE; REVIEW;

EID: 0033944472     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.2000.0057     Document Type: Article

References (29)

1. Abramson F P, Osborn B L, Teffera Y. Isotopic differences in human growth hormone preparations. Analytical Chemistry. 68:1996;1971-1972.
2. Healy M L, Russell-Jones D. Growth hormone and sport: abuse, potential benefits, and difficulties in detection. British Journal of Sports Medicine. 31:1997;267-268.
3. Kanaley J A, Weatherup-Dentes M M, Jaynes E B, Hartman M L. Obesity attenuates the growth hormone response to exercise. Journal of Clinical Endocrinology and Metabolism. 84:1999;3156-3161.
4. Kraemer W J, Hakkinen K, Newton R U. Effects of heavy-resistance training on hormonal response patterns in younger vs. older men. Journal of Applied Physiology. 87:1999;982-992.
5. Eliakim A, Brasel J A, Mohan S. Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females. Journal of Clinical Endocrinology and Metabolism. 81:1996;3986-3992.
6. Harrela M, Koistinen H, Kaprio J. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. Journal of Clinical Investigation. 98:1996;2612-2615.
7. Juul A, Main K, Blum W F. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clinical Endocrinology. 41:1994;85-93.
8. Juul A, Dalgaard P, Blum W F. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. Journal of Clinical Endocrinology and Metabolism. 80:1995;2534-2542.
9. Bang P, Brandt J, Degerblad M. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. European Journal of Clinical Investigation. 20:1990;285-292.
10. Hopkins N J, Jakeman P M, Hughes S C, Holly J M. Changes in circulating insulin-like growth factor-binding protein-1 (IGFBP-1) during prolonged exercise: effect of carbohydrate feeding. Journal of Clinical Endocrinology and Metabolism. 79:1994;1887-1890.
11. Hornum M, Cooper D M, Brasel J A. Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women. Journal of Applied Physiology. 82:1997;1946-1951.
12. Kraemer W J, Aguilera B A, Terada M. Responses of IGF-I to endogenous increases in growth hormone after heavy-resistance exercise. Journal of Applied Physiology. 79:1995;1310-1315.
13. Poehlman E T, Rosen C J, Copeland K C. The influence of endurance training on insulin-like growth factor-1 in older individuals. Metabolism: Clinical and Experimental. 43:1994;1401-1405.
14. Schwarz A J, Brasel J A, Hintz R L. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. Journal of Clinical Endocrinology and Metabolism. 81:1996;3492-3497.
15. Karila T, Koistinen H, Seppala M. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes. Clinical Endocrinology. 49:1998;459-463.
16. Browne A, Lachance V, Pipe A. The ethics of blood testing as an element of doping control in sport. Medicine and Science in Sports and Exercise. 31:1999;497-501.
17. Leger J, Reverchon C, Porquet D. The wide variation in urinary excretion of human growth hormone in normal growing and growth hormone-deficient children limits its clinical usefulness. Hormone Research. 44:1995;57-63.
18. Flanagan D E, Taylor M C, Parfitt V. Urinary growth hormone following exercise to assess growth hormone production in adults. Clinical Endocrinology. 46:1997;425-429.
19. Saugy M, Cardis C, Schweizer C. Detection of human growth hormone doping in urine: out of competition tests are necessary. Journal of Chromatography B, Biomedical Applications. 687:1996;201-211.
20. Holl R W, Schwarz U, Schauwecker P. Diurnal variation in the elimination rate of human growth hormone (GH): the half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol. Journal of Clinical Endocrinology and Metabolism. 77:1993;216-220.
21. Arcelloni C, Fermo I, Banfi G. Capillary electrophoresis for protein analysis: separation of human growth hormone and human insulin molecular forms. Analytical Biochemistry. 212:1993;160-167.
22. Baumann G. Growth hormone heterogeneity in human pituitary and plasma. Hormone Research. 51:1999;2-6.
23. Koistinen H, Koistinen R, Selenius L. Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels. Journal of Applied Physiology. 80:1996;760-764.
24. Wallace J D, Cuneo R C, Baxter R. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. Journal of Clinical Endocrinology and Metabolism. 84:1999;3591-3601.
25. Longobardi, S, Keay, N, Ehrnborg, C, Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential usefulness in the detection of GH sport abuse: a double blind, placebo-controlled study, 1999, P2-543, Bethesda, MD, The Endocrine Society Press, 1999.
26. Wu Z, Bidlingmaier M, Dall R, Strasburger C J. Detection of doping with human growth hormone. Lancet. 353:1999;895.
27. Jenkins P. Detection of doping. Lancet. 373:1999;1532.
28. Hashimoto Y, Ikeda I, Ikeda M. Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone. Journal of Immunological Methods. 221:1998;77-85.
29. Baumann G. Growth hormone binding proteins and various forms of growth hormone: implications for measurements. Acta Paediatrica Scandinavica. 370:1990;72-80.